These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3113703)

  • 21. Nandrolone decanoate for men with osteoporosis.
    Hamdy RC; Moore SW; Whalen KE; Landy C
    Am J Ther; 1998 Mar; 5(2):89-95. PubMed ID: 10099043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.
    Hassager C; Jensen LT; Johansen JS; Riis BJ; Melkko J; Pødenphant J; Risteli L; Christiansen C; Risteli J
    Metabolism; 1991 Feb; 40(2):205-8. PubMed ID: 1988778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG; Nordin BE; Chatterton BE
    Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.
    Need AG; Philcox JC; Hartley TF; Nordin BE
    Aust N Z J Med; 1986 Jun; 16(3):341-6. PubMed ID: 3465310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
    Lyritis GP; Androulakis C; Magiasis B; Charalambaki Z; Tsakalakos N
    Bone Miner; 1994 Dec; 27(3):209-17. PubMed ID: 7696887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.
    Caniggia A; Nuti R; Loré F; Vattimo A
    J Endocrinol Invest; 1984 Aug; 7(4):373-8. PubMed ID: 6094649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?
    Birkenhäger JC; Erdtsieck RJ; Zeelenberg J; van Kuik C; van Veen LC; Birkenhäger-Frenkel DH; Luiken GP; Kooy PP; Gerritsma EJ; Mulder P
    Bone Miner; 1992 Sep; 18(3):251-65. PubMed ID: 1392698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anabolic steroids and osteoporosis.
    Dequeker J; Geusens P
    Acta Endocrinol Suppl (Copenh); 1985; 271():45-52. PubMed ID: 3865481
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on osteoporosis VII. Effect of 17 beta-hydroxy-4-estren-3-one 17-decanoate on experimental osteoporosis.
    Robin JC; Suh OW; Ambrus JL
    Steroids; 1982 Aug; 40(2):125-32. PubMed ID: 7157449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment.
    Huang RY; Miller LM; Carlson CS; Chance MR
    Bone; 2002 Mar; 30(3):492-7. PubMed ID: 11882463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.
    Hartwell D; Riis BJ; Christiansen C
    Calcif Tissue Int; 1990 Dec; 47(6):332-7. PubMed ID: 2292078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium metabolism in postmenopausal and osteoporotic women consuming two levels of dietary protein.
    Lutz J; Linkswiler HM
    Am J Clin Nutr; 1981 Oct; 34(10):2178-86. PubMed ID: 7293944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of calcitonin or the anabolic steroid Decadurabolin on serum beta 2 microglobulin in osteoporotic postmenopausal women.
    Cantatore FP; Loperfido MC; Mancini L; Carrozzo M
    J Rheumatol; 1992 Nov; 19(11):1753-5. PubMed ID: 1491396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.
    Hartwell D; Hassager C; Overgaard K; Riis BJ; Pødenphant JR; Christiansen C
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):715-21. PubMed ID: 2375235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
    Riggs BL; Nelson KI
    J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of influence of the anabolic steroid nandrolondecanoate on bone metabolism.
    Bijlsma JW; Duursma SA; Bosch R; Huber O
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):140-3. PubMed ID: 7124288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
    Hassager C; Riis BJ; Pødenphant J; Christiansen C
    Maturitas; 1989 Dec; 11(4):305-17. PubMed ID: 2693918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical effects of a calcium supplement in osteoporotic postmenopausal women with normal absorption and malabsorption of calcium.
    Need AG; Horowitz M; Philcox JC; Nordin BE
    Miner Electrolyte Metab; 1987; 13(2):112-6. PubMed ID: 3696089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.